News Archive

Of patients studied, only one-third of those who had had a stroke were receiving guideline-recommended statin therapy, while nearly a quarter of these patients were not receiving any statins.

Mixed results from the CABANA trial have led to debate about whether catheter ablation is an effective treatment option that provides benefit to patients with atrial fibrillation.

Research from DCRI investigators will help determine whether medications prescribed off-label to individuals with Down syndrome are safe and effective.

A new faculty member has joined the DCRI’s musculoskeletal group.

Research guidance recently issued by the FDA provides clarity regarding clinical trial study design, drug dosing, and analysis in studies of newborns.

The meeting summary highlights gaps in evidence about the dangers of vaping and e-cigarette use to youth, as well as key takeaways and strategies to combat youth tobacco use.

Recently published results explore reasons behind the well-documented phenomenon of gendered differences in statin use.

Evidence supports that implantable cardioverter defibrillators still provide life-saving benefits, but more research is needed to improve the selection of patients for this treatment.

A study led by a DCRI faculty member provides additional clarification on which patients may benefit the most from additional lipid-lowering therapies, if their cholesterol levels remain elevated despite optimal statin therapy.

Recent findings suggest that elevations in low-density lipoprotein cholesterol levels may not confer additional risk in populations 75 or older.